Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GST Polymorphism on Amoxicillin/Clavulanate PK/PD and DILI Biomarkers
NCT02143323Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of amoxicillin + clavulanate in bacterial infection (4 arms), sponsored by Seoul National University Hospital. Primary endpoints: Aspartate Aminotransferase at 22 days, Alanine Aminotransferase at 22 days and 1 more. Started Dec 2013; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02143323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143323.